4SC AG INH. O.N./ DE000A3E5C40 /
| 20/12/2024 11:41:30 | Diferencia +0.1400 | Volumen | Bid11:41:30 | Ask19:57:31 | Capitalización de mecado | Dividendo A. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.0100EUR | +3.62% | 60 Volumen de negocios: 240.6000 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 40.56 millonesEUR | - | - |
GlobeNewswire
05/12/2023
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
01/04/2019
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
11/06/2018
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018
